| # | Drug | Count |
|---|---|---|
| 0 | DICLOFENAC | 20 |
| 1 | DICLOFENAC SODIUM | 20 |
| 2 | ALCOHOL | 15 |
| 3 | ERGOCALCIFEROL | 15 |
| 4 | ISOPROPYL ALCOHOL | 15 |
| 5 | SECUKINUMAB | 15 |
| 6 | 70%ISOPROPYL ALCOHOL | 14 |
| 7 | DICLOFENAC SODIUM 1% | 14 |
| 8 | DICLOFENAC SODIUM TOPICAL | 14 |
| 9 | DICLOFENAC SODIUM TOPICAL GEL, 1% | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CHLORHEXIDINE GLUCONATE AND ISOPROPYL ALCOHOL | 1 | 0.0033 |
| 1 | CAFFEINE CITRATE | 6 | 0.0026 |
| 2 | HYDROCORTISONE SODIUM SUCCINATE | 10 | 0.0025 |
| 3 | NEOMYCIN OINTMENT | 5 | 0.0020 |
| 4 | HYDROCORTISONE BUTYRATE | 4 | 0.0020 |
| 5 | TRICLOSAN | 1 | 0.0017 |
| 6 | HEMIN | 1 | 0.0017 |
| 7 | CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE | 1 | 0.0015 |
| 8 | DICLOFENAC POTASSIUM TABLETS | 13 | 0.0015 |
| 9 | APREPITANT | 11 | 0.0015 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 23 |
| 1 | Corticosteroid [EPC] | 16 |
| 2 | Aminosalicylate [EPC] | 15 |
| 3 | Interleukin-17A Antagonist [EPC] | 15 |
| 4 | Opioid Agonist [EPC] | 15 |
| 5 | Provitamin D2 Compound [EPC] | 15 |
| 6 | Vitamin C [EPC] | 15 |
| 7 | Antirheumatic Agent [EPC] | 14 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 14 |
| 9 | Interleukin-6 Receptor Antagonist [EPC] | 14 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Endoglycosidase [EPC] | 6 | 0.0032 |
| 1 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 2 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 11 | 0.0013 |
| 3 | 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] | 1 | 0.0012 |
| 4 | Provitamin D2 Compound [EPC] | 15 | 0.0005 |
| 5 | Interleukin-17A Antagonist [EPC] | 15 | 0.0004 |
| 6 | Calcitonin [EPC] | 1 | 0.0003 |
| 7 | Human C1 Esterase Inhibitor [EPC] | 1 | 0.0003 |
| 8 | Antiseptic [EPC] | 1 | 0.0002 |
| 9 | alpha-1 Adrenergic Agonist [EPC] | 1 | 0.0002 |